Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values
AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic l...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 22; no. 10; pp. 3031 - 3037 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
14.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve(ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group(P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group(P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group(P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10-3 mm2/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity. |
---|---|
AbstractList | To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).AIMTo determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.METHODSIn total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.RESULTSThere was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.CONCLUSIONDWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity. AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC) values of diffusion-weighted imaging(DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer(156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve(ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group(P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group(P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group(P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10-3 mm2/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity. AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI). METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient’s sensitivity and specificity degree of efficacy to the chemotherapy. RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group ( P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group ( P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group ( P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10 -3 mm 2 /s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity. To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI). In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy. There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively. DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity. |
Author | De-Xian Zheng Shu-Chun Meng Qing-Jun Liu Chuan-Ting Li Xi-Dan Shang Yu-Seng Zhu Tian-Jun Bai Shi-Ming Xu |
AuthorAffiliation | Department of Radiology,Second People’s Hospital of Liaocheng City;Department of Radiology,Third People’s Hospital of Liaocheng city;Medical Imaging Institute of Shandong Province,Shandong Provincial Hospital;Department of Gastroenterology,Second People’s Hospital of Liaocheng city;Department of Radiology,People’s Hospital of Liaocheng city |
Author_xml | – sequence: 1 givenname: De-Xian surname: Zheng fullname: Zheng, De-Xian – sequence: 2 givenname: Shu-Chun surname: Meng fullname: Meng, Shu-Chun – sequence: 3 givenname: Qing-Jun surname: Liu fullname: Liu, Qing-Jun – sequence: 4 givenname: Chuan-Ting surname: Li fullname: Li, Chuan-Ting – sequence: 5 givenname: Xi-Dan surname: Shang fullname: Shang, Xi-Dan – sequence: 6 givenname: Yu-Seng surname: Zhu fullname: Zhu, Yu-Seng – sequence: 7 givenname: Tian-Jun surname: Bai fullname: Bai, Tian-Jun – sequence: 8 givenname: Shi-Ming surname: Xu fullname: Xu, Shi-Ming |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26973399$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UctqHDEQFMEhXm9yzynomMts9JrR6BIIxnmAITkkZ6HRSLMys9Ja0q7xOT-eHrx2HocIgZpWVXXRdYHOYooOodeUbLgU_bu7m2lzZGwTlgbh9BlaMUZVw3pBztCKEiIbxZk8Rxel3BDCOG_ZC3TOOiU5V2qFfn7Lbgy2hjjhORxdxjtXTYEbCk4eT1DnFGJ1BTBmxjUbW7E10QJ2uMdj8P5QQorNnQvTtroRh52ZFj2gm_3eZBfrbxi2yXkfbFi6RzMfXHmJnnszF_fq9K7Rj49X3y8_N9dfP325_HDdWCFIbbj0o-yd6AdrrCRqoJ1ouR066axpPXOWU6OU5YwaqVrOCRHDMBJvad9xKvgavX_Q3R-GnRstOMhm1vsMhvO9Tibov39i2OopHbWQUinWgcDbk0BOt2C86l0o1s2ziS4diqZScsEJBVtr9ObPWU9DHjcPgO4BYHMqJTuvbaimwoZgdJg1JXqJWEPEGiLWYWlAxEAk_xAftf9D4SfKNsXpFrJ54ijSL0e1RPRCtUIoeJeq478AT22-rg |
CitedBy_id | crossref_primary_10_1016_j_ejro_2022_100399 crossref_primary_10_1155_2022_5132135 crossref_primary_10_2478_raon_2021_0052 crossref_primary_10_4254_wjh_v9_i26_1081 crossref_primary_10_1002_adma_202007603 crossref_primary_10_1259_bjr_20181044 crossref_primary_10_1002_jso_26875 crossref_primary_10_24835_1607_0763_2017_6_49_62 |
Cites_doi | 10.1148/radiol.12120167 10.1016/j.jss.2014.07.036 10.1158/1078-0432.CCR-12-2738 10.1093/neuonc/nos314 10.1097/COC.0b013e318209cd8f 10.1016/j.ejphar.2010.09.019 10.1097/MD.0000000000000517 10.1016/S1726-4901(09)70379-X 10.1093/neuonc/not153 10.1007/s10151-013-1069-9 10.1093/jjco/hyr037 10.1002/jmri.23915 10.1016/j.crad.2013.11.005 10.3748/wjg.v20.i7.1650 10.12998/wjcc.v3.i3.231 10.1016/j.mri.2013.12.007 10.1148/radiol.13130866 10.1021/mp300582s 10.1097/COC.0b013e3181a650fb 10.1007/s00104-013-2660-3 10.1097/SMJ.0b013e3181b67356 10.1007/s00330-014-3573-3 10.1002/nbm.3014 10.3748/wjg.v19.i9.1485 10.1148/radiol.14132084 10.1007/s00595-009-4099-1 10.1002/jmri.23804 10.1371/journal.pone.0072679 10.3748/wjg.v20.i5.1180 10.3348/kjr.2013.14.4.616 10.1007/s00261-013-0032-6 10.1148/radiol.13131810 10.3748/wjg.v21.i5.1621 |
ContentType | Journal Article |
Copyright | The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016 |
Copyright_xml | – notice: The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. 2016 |
DBID | 2RA 92L CQIGP ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.3748/wjg.v22.i10.3031 |
DatabaseName | 中文科技期刊数据库 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values |
EISSN | 2219-2840 |
EndPage | 3037 |
ExternalDocumentID | PMC4779926 26973399 10_3748_wjg_v22_i10_3031 90888889504849544948484956 |
Genre | Journal Article Comparative Study Observational Study |
GroupedDBID | --- 123 29R 2B. 2C~ 2RA 2WC 36B 53G 5VR 8WL 92F 92I 92L 93N 93R AAKDD ACGFO AENEX AFUIB ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CQIGP CS3 CW9 DIK DU5 E3Z EBS EJD EMB F5P FA0 FRP GX1 HYE M~E OK1 P2P RNS RPM SV3 TCJ TGQ TR2 WFFXF XSB ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c440t-37fd78e48bcac709b16453cb67eca5f2ec31a99c321a79533004bbd0fc1863143 |
ISSN | 1007-9327 2219-2840 |
IngestDate | Thu Aug 21 17:33:35 EDT 2025 Fri Jul 11 07:35:10 EDT 2025 Thu Jan 02 22:20:17 EST 2025 Tue Jul 01 01:54:10 EDT 2025 Thu Apr 24 22:52:57 EDT 2025 Wed Feb 14 10:13:35 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 10 |
Keywords | Gastrointestinal tract cancer Chemotherapy Magnetic resonance imaging Liver metastatic tumor |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c440t-37fd78e48bcac709b16453cb67eca5f2ec31a99c321a79533004bbd0fc1863143 |
Notes | De-Xian Zheng;Shu-Chun Meng;Qing-Jun Liu;Chuan-Ting Li;Xi-Dan Shang;Yu-Seng Zhu;Tian-Jun Bai;Shi-Ming Xu;Department of Radiology,Second People’s Hospital of Liaocheng City;Department of Radiology,Third People’s Hospital of Liaocheng city;Medical Imaging Institute of Shandong Province,Shandong Provincial Hospital;Department of Gastroenterology,Second People’s Hospital of Liaocheng city;Department of Radiology,People’s Hospital of Liaocheng city ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 Author contributions: Zheng DX and Meng SC designed research; Zheng DX, Meng SC, Liu QJ and Li CT performed research; Meng SC, Liu QJ, Li CT, Shang XD and Zhu YS contributed new reagents/analytic tools; Zheng DX and Meng SC analyzed data; Zheng DX and Meng SC wrote the paper; All the authors contributed to this manuscript. Telephone: +86-635-8385120 Correspondence to: Shu-Chun Meng, Deputy Chief Physician, Department of Radiology, Third People’s Hospital of Liaocheng city, Shandong No. 62 Weiyu Road of Liaocheng city, 60 Weiyu Road, Liaocheng 252000, Shandong Province, China. zhengdexianx@sina.com |
OpenAccessLink | https://www.wjgnet.com/1007-9327/full/v22/i10/3031.htm |
PMID | 26973399 |
PQID | 1773430145 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4779926 proquest_miscellaneous_1773430145 pubmed_primary_26973399 crossref_citationtrail_10_3748_wjg_v22_i10_3031 crossref_primary_10_3748_wjg_v22_i10_3031 chongqing_primary_90888889504849544948484956 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-03-14 |
PublicationDateYYYYMMDD | 2016-03-14 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | World journal of gastroenterology : WJG |
PublicationTitleAlternate | World Journal of Gastroenterology |
PublicationYear | 2016 |
Publisher | Baishideng Publishing Group Inc |
Publisher_xml | – name: Baishideng Publishing Group Inc |
References | ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 24327584 - Neuro Oncol. 2014 Jan;16(1):131-9 23275575 - Neuro Oncol. 2013 Mar;15(3):382-90 23560393 - Mol Pharm. 2013 May 6;10(5):1783-94 24512795 - Magn Reson Imaging. 2014 May;32(4):342-9 23532891 - Clin Cancer Res. 2013 May 1;19(9):2518-27 21336090 - Am J Clin Oncol. 2012 Apr;35(2):158-62 24072381 - Abdom Imaging. 2014 Feb;39(1):2-17 23151830 - Radiology. 2013 Feb;266(2):531-8 24471389 - Radiology. 2014 Feb;270(2):400-8 19738517 - South Med J. 2009 Oct;102(10):1032-40 21459893 - Jpn J Clin Oncol. 2011 Jun;41(6):770-5 24057356 - Tech Coloproctol. 2014 Jun;18(6):521-7 23148046 - J Magn Reson Imaging. 2013 Jul;38(1):206-9 19806036 - Am J Clin Oncol. 2010 Jun;33(3):242-5 23018989 - J Magn Reson Imaging. 2013 Jan;37(1):187-93 24360516 - Clin Radiol. 2014 Apr;69(4):378-84 25145903 - J Surg Res. 2014 Dec;192(2):312-6 25789296 - World J Clin Cases. 2015 Mar 16;3(3):231-44 25663782 - World J Gastroenterol. 2015 Feb 7;21(5):1621-7 20496139 - Surg Today. 2010 Jun;40(6):561-5 24475862 - Radiology. 2014 May;271(2):416-25 24587644 - World J Gastroenterol. 2014 Feb 21;20(7):1650-6 25605133 - Eur Radiol. 2015 Jul;25(7):2033-40 23901319 - Korean J Radiol. 2013 Jul-Aug;14(4):616-25 25674749 - Medicine (Baltimore). 2015 Feb;94(6):e517 24574794 - World J Gastroenterol. 2014 Feb 7;20(5):1180-91 24038282 - NMR Biomed. 2013 Dec;26(12):1762-7 19541568 - J Chin Med Assoc. 2009 Jun;72(6):323-7 24533873 - Radiology. 2014 Jun;271(3):672-80 23538460 - World J Gastroenterol. 2013 Mar 7;19(9):1485-8 24449083 - Chirurg. 2014 Sep;85(9):806-11 20863829 - Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35 23991141 - PLoS One. 2013;8(8):e72679 |
References_xml | – ident: ref18 doi: 10.1148/radiol.12120167 – ident: ref4 doi: 10.1016/j.jss.2014.07.036 – ident: ref28 doi: 10.1158/1078-0432.CCR-12-2738 – ident: ref31 doi: 10.1093/neuonc/nos314 – ident: ref12 doi: 10.1097/COC.0b013e318209cd8f – ident: ref7 doi: 10.1016/j.ejphar.2010.09.019 – ident: ref9 doi: 10.1097/MD.0000000000000517 – ident: ref20 doi: 10.1016/S1726-4901(09)70379-X – ident: ref26 doi: 10.1093/neuonc/not153 – ident: ref3 doi: 10.1007/s10151-013-1069-9 – ident: ref19 doi: 10.1093/jjco/hyr037 – ident: ref6 doi: 10.1002/jmri.23915 – ident: ref25 doi: 10.1016/j.crad.2013.11.005 – ident: ref29 doi: 10.3748/wjg.v20.i7.1650 – ident: ref1 doi: 10.12998/wjcc.v3.i3.231 – ident: ref11 doi: 10.1016/j.mri.2013.12.007 – ident: ref24 doi: 10.1148/radiol.13130866 – ident: ref17 doi: 10.1021/mp300582s – ident: ref15 doi: 10.1097/COC.0b013e3181a650fb – ident: ref2 doi: 10.1007/s00104-013-2660-3 – ident: ref8 doi: 10.1097/SMJ.0b013e3181b67356 – ident: ref21 doi: 10.1007/s00330-014-3573-3 – ident: ref27 doi: 10.1002/nbm.3014 – ident: ref10 doi: 10.3748/wjg.v19.i9.1485 – ident: ref22 doi: 10.1148/radiol.14132084 – ident: ref14 doi: 10.1007/s00595-009-4099-1 – ident: ref33 doi: 10.1002/jmri.23804 – ident: ref13 doi: 10.1371/journal.pone.0072679 – ident: ref32 doi: 10.3748/wjg.v20.i5.1180 – ident: ref16 doi: 10.3348/kjr.2013.14.4.616 – ident: ref5 doi: 10.1007/s00261-013-0032-6 – ident: ref23 doi: 10.1148/radiol.13131810 – ident: ref30 doi: 10.3748/wjg.v21.i5.1621 – reference: 20863829 - Eur J Pharmacol. 2010 Dec 15;649(1-3):328-35 – reference: 25605133 - Eur Radiol. 2015 Jul;25(7):2033-40 – reference: 24038282 - NMR Biomed. 2013 Dec;26(12):1762-7 – reference: 19541568 - J Chin Med Assoc. 2009 Jun;72(6):323-7 – reference: 25674749 - Medicine (Baltimore). 2015 Feb;94(6):e517 – reference: 20496139 - Surg Today. 2010 Jun;40(6):561-5 – reference: 24587644 - World J Gastroenterol. 2014 Feb 21;20(7):1650-6 – reference: 23538460 - World J Gastroenterol. 2013 Mar 7;19(9):1485-8 – reference: 23148046 - J Magn Reson Imaging. 2013 Jul;38(1):206-9 – reference: 24057356 - Tech Coloproctol. 2014 Jun;18(6):521-7 – reference: 24360516 - Clin Radiol. 2014 Apr;69(4):378-84 – reference: 25145903 - J Surg Res. 2014 Dec;192(2):312-6 – reference: 25789296 - World J Clin Cases. 2015 Mar 16;3(3):231-44 – reference: 24449083 - Chirurg. 2014 Sep;85(9):806-11 – reference: 24327584 - Neuro Oncol. 2014 Jan;16(1):131-9 – reference: 24471389 - Radiology. 2014 Feb;270(2):400-8 – reference: 25663782 - World J Gastroenterol. 2015 Feb 7;21(5):1621-7 – reference: 23991141 - PLoS One. 2013;8(8):e72679 – reference: 21336090 - Am J Clin Oncol. 2012 Apr;35(2):158-62 – reference: 23275575 - Neuro Oncol. 2013 Mar;15(3):382-90 – reference: 24072381 - Abdom Imaging. 2014 Feb;39(1):2-17 – reference: 21459893 - Jpn J Clin Oncol. 2011 Jun;41(6):770-5 – reference: 19806036 - Am J Clin Oncol. 2010 Jun;33(3):242-5 – reference: 23560393 - Mol Pharm. 2013 May 6;10(5):1783-94 – reference: 24574794 - World J Gastroenterol. 2014 Feb 7;20(5):1180-91 – reference: 24475862 - Radiology. 2014 May;271(2):416-25 – reference: 19738517 - South Med J. 2009 Oct;102(10):1032-40 – reference: 24512795 - Magn Reson Imaging. 2014 May;32(4):342-9 – reference: 23151830 - Radiology. 2013 Feb;266(2):531-8 – reference: 23532891 - Clin Cancer Res. 2013 May 1;19(9):2518-27 – reference: 24533873 - Radiology. 2014 Jun;271(3):672-80 – reference: 23018989 - J Magn Reson Imaging. 2013 Jan;37(1):187-93 – reference: 23901319 - Korean J Radiol. 2013 Jul-Aug;14(4):616-25 |
SSID | ssj0023352 |
Score | 2.2073686 |
Snippet | AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient(ADC)... To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values... AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC)... |
SourceID | pubmedcentral proquest pubmed crossref chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3031 |
SubjectTerms | Adult Aged Antineoplastic Agents - therapeutic use Area Under Curve cancer Chemotherapy;Liver Diffusion Magnetic Resonance Imaging Female Gastrointestinal Neoplasms - pathology Humans imaging;Gastrointestinal Liver Neoplasms - diagnostic imaging Liver Neoplasms - drug therapy Liver Neoplasms - secondary Male metastatic Middle Aged Observational Study Predictive Value of Tests Reproducibility of Results resonance ROC Curve Time Factors tract Treatment Outcome Tumor Burden tumor;Magnetic |
Title | Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values |
URI | http://lib.cqvip.com/qk/84123X/201610/90888889504849544948484956.html https://www.ncbi.nlm.nih.gov/pubmed/26973399 https://www.proquest.com/docview/1773430145 https://pubmed.ncbi.nlm.nih.gov/PMC4779926 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLWq8cILYuKrfMlIvCCRLnEcu3lEAzRVGgLRiYqXyHbjtmik0DVM8Mpf4Ydyr-2kabdJjD5E0a1zZeWe2Nf28TEhz5mwwiglIqUNjzhHEoBw8toyVyJVkM_hBufjd-LohI8m2aTX-9NhLdVrPTC_Lt1X8j9RBRvEFXfJXiOyrVMwwD3EF64QYbj-U4zfr3CZxRGXT5FfgedBK0j3gsjIDO5XSxSEgO_Ys8pxR6TBQK8w78TTUWqcLovO3QwpJJ-Lr-HYIoty48ppN7XFUEnESU6gFWXCAwExJLeemNPRovAVQNXPlZd6wvmHT6P2OK_P89I3Na_LaNLB6XEwf5zX0eG83rCGFjWaP0AFo1HX7IkDtaqicdMVh5mMRCCVy-8gDY0vTptCPim7rTNjXRTGnbYWOt_ksk4ABXUgcudfZoMfjA0WaApFt_W2d_rBlp0I4yL0UYCHAjwUCzTEuFn_BoPBCGvmhMKwHnetuTX1UHu_GI4eDnbrgAIe82U1-w7vYjsRujC62SXpdrKe8W1yKwxX6CuPvX3SK6s75PcGd9Thjm5wR5eW7uKOOtxRjzuqf9KLuKMBd_h4g7tNMdrBHfW4u0tO3r4ZHx5F4TCPyHAer6Ejs1M5LPlQG2VknGsYp2ep0UKWRmWWlSZNVJ6blCVKOs5zzLWextYkQ5FCVn-P7FXLqnyAbDxtmM6t5anlQhgdT63IcguZaCbVMO2Tl-1bLr550ZYC-XzwyzPosniecZRFcneiTw6aQBQmCOPj-SynxVVA6JMX7RON_6vLPmtiW0DLjctxqiqX9VmRSJlynNHI-uS-j3XrjYlcpjB26BO5hYK2AKrCb_9TLeZOHZ5LmedMPLxGHR-Rm5vv8THZW6_q8gnk2mv91EH9L-UZ3Bk |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+liver+metastasis+of+gastrointestinal+tract+cancer+by+diffusion-weighted+imaging+of+apparent+diffusion+coefficient+values&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Zheng%2C+De-Xian&rft.au=Meng%2C+Shu-Chun&rft.au=Liu%2C+Qing-Jun&rft.au=Li%2C+Chuan-Ting&rft.date=2016-03-14&rft.issn=1007-9327&rft.volume=22&rft.issue=10&rft.spage=3031&rft_id=info:doi/10.3748%2Fwjg.v22.i10.3031&rft.externalDBID=n%2Fa&rft.externalDocID=10_3748_wjg_v22_i10_3031 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg |